Drugs / EPA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07304921 | Apr → Jun 2023 | inherited lipid metabolism disorder | Riga Stradins University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPA | “PUFA supplement (930 mg EPA and 750 mg DHA) for four weeks” NCT07304921 ↗ |